Aspen Aerogels (NYSE:ASPN) Hits New 1-Year Low – Should You Sell?

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) reached a new 52-week low on Wednesday . The company traded as low as $7.45 and last traded at $7.50, with a volume of 2443166 shares changing hands. The stock had previously closed at $7.77.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ASPN. Barclays reduced their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 19th. Craig Hallum reduced their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Friday, February 14th. Roth Mkm lowered their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th. B. Riley dropped their price target on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research report on Wednesday, February 19th. Finally, Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.44.

Aspen Aerogels Trading Down 3.5 %

The stock has a market capitalization of $614.96 million, a P/E ratio of 46.85 and a beta of 2.14. The stock’s fifty day moving average price is $11.44 and its 200 day moving average price is $17.86. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Research analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Institutional Trading of Aspen Aerogels

Hedge funds have recently added to or reduced their stakes in the business. Sandia Investment Management LP bought a new stake in shares of Aspen Aerogels in the 4th quarter valued at about $89,000. AlphaQuest LLC raised its stake in Aspen Aerogels by 54.0% in the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after buying an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of Aspen Aerogels in the 4th quarter worth $164,000. Connors Investor Services Inc. bought a new stake in Aspen Aerogels during the fourth quarter valued at about $168,000. Finally, Journey Strategic Wealth LLC bought a new position in Aspen Aerogels in the fourth quarter worth about $178,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.